Drug Shortage Report for TEVA-CANDESARTAN/HCTZ

Last updated on 2020-08-21 History
Report ID 120878
Drug Identification Number 02395568
Brand name TEVA-CANDESARTAN/HCTZ
Common or Proper name CANDESARTAN/HCTZ 32/12.5MG TB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE
Strength(s) 32MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size P/P 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-22
Estimated end date 2020-08-31
Actual end date 2020-08-20
Shortage status Resolved
Updated date 2020-08-21
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-07-23 English Compare
v2 2020-07-23 French Compare
v3 2020-08-20 English Compare
v4 2020-08-20 French Compare
v5 2020-08-21 English Compare